CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS

This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compou...

Full description

Saved in:
Bibliographic Details
Main Authors FRIEDMAN, MICHAEL M, VASUDEVAN, ANIL, FRANK, KRISTINE E, JOSEPHSOHN, NATHAN, NG, TERESA, GOMTSIAN, ARTOUR, DEKHTYAR, TATYANA, MOLLA, M-AKHTERUZZ, SHAFEEV, MIKHAIL
Format Patent
LanguageEnglish
French
Published 03.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. La présente invention concerne : (a) des composés et des sels de ceux-ci qui, entre autres, empêchent la réplication et/ou l'infection par le VRS ; (b) des intermédiaires utiles pour la préparation de tels composés et sels ; (c) des compositions comprenant de tels composés et sels ; (d) des méthodes de préparation de tels intermédiaires, composés, sels et compositions ; (e) des méthodes d'utilisation de tels composés, sels et compositions ; et (f) des nécessaires comprenant de tels composés, sels et compositions.
Bibliography:Application Number: CA20132877326